![](/img/cover-not-exists.png)
Drop of FGF19 levels in patients with HCC development following DAA therapy for chronic hepatitis C
Stadlbauer, V., Schmerböck, B., Leber, B., Kipperer, M., Stiegler, P., Posch, A., Streit, A., Spindelböck, W., Fickert, P., Stauber, R.Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(17)31903-7
File:
PDF, 165 KB
english, 2017